Task: Answer the multiple-choice question.
Question: Which drug exhibits a -16.917% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) COc1ccc(-c2cc(C)nc(SCC(=O)c3cccc([N+](=O)[O-])c3)n2)cc1
(b) CCCOC(=O)CCn1c(=S)oc2ccccc21
(c) O=C(CSc1ncnc2sccc12)NCc1ccc2c(c1)OCO2
(d) CCC1CCc2[nH]nc(C(=O)O)c2C1
Answer: c. O=C(CSc1ncnc2sccc12)NCc1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1ncnc2sccc12)NCc1ccc2c(c1)OCO2
O=C(CSc1ncnc2sccc12)NCc1ccc2c(c1)OCO2
N-(1,3-benzodioxol-5-ylmethyl)-2-thieno[2,3-d]pyrimidin-4-ylsulfanylacetamide